Role of Nanotechnology in AnthraquinonesMediated Disease Management

Preview this chapter:

Role of Nanotechnology in AnthraquinonesMediated Disease Management, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815313987/chapter-5-1.gif

To maintain therapeutic efficacy while reducing toxicity and biocompatibility, innovative safety delivery techniques with improved nanotechnology are developed. Nanotechnology develops delivery systems that enhance the solubilizing and release quality of drugs, as well as their circulation time, which is important to enhance the therapeutic efficacy of drugs. Anthraquinones are organic substances that may be found in various plants, animals, and even some marine life. They are simple anthrones or bianthrones chemically speaking. They are used as pigments, dyes, and pharmaceuticals. Anthraquinone glycosides possess biological qualities including laxative, anti-inflammatory, anti-cancer, and antioxidants. Anthraquinones have certain drawbacks, such as their poor solubility in aqueous media, which restricts the routes of administration and lowers their bioavailability while also exhibiting a lower degree of selectivity for target tissues. It is speculated that anthraquinones and nanostructures work together. This chapter describes the application of nanotechnology in the treatment of anthraquinone-mediated diseases. The utilization of anthraquinone-loaded nanoparticles, nanocapsules, and nanocarriers in the treatment of various illnesses is highlighted.